A new Collection in Ther Adv Med Oncol examines how biomarker‑driven strategies are shaping lung cancer care across the disease continuum.
Deadline: 29 Jan 2027
buff.ly/RrkerAu
#LungCancer #PrecisionOncology #Biomarkers #MedicalOncology
Prospective study (Ukraine/Moldova/Spain, n=287): mfloDx™ MDR-TB assay achieved Se 100% / Sp 98.7% for INH+RIF resistance vs culture DST. Caveat: 35% inconclusive results. Potential role as rapid screening tool.
journals.sagepub.com/doi/full/10....
Top Read Papers on Natural Product Communications - April 2026
💡4. Evaluation of Membrane-Stabilizing and Clot-Lysing Activities of the Chloroform Fraction of Curcuma wallichii Rhizomes: An in vitro Model With Molecular Docking
journals.sagepub.com/doi/10.1177/...
Top Read Papers on Natural Product Communications - April 2026
💡5. From Folk Remedies to Future Formulations: A Review on Phytochemistry, Ethnobotanical Use and Emerging Pharmacological Insights of Teucrium Species
journals.sagepub.com/doi/10.1177/...
💡 Editorial Review Board Member of the month - April 2026
This month, we interviewed Prof. Emel Unal Turhan, a Professor of food microbiology, food safety, and fermentation at Adana Alparslan Türkeş Science and Technology University in Turkiye.
Read more: journals.sagepub.com/page/npx/erb...
The therapeutic landscape of HR+HER2‑ advanced #BreastCancer has expanded rapidly, yet heterogeneity, resistance, and treatment sequencing remain unresolved challenges. This Collection in Ther Adv Med Oncol focuses on research shaping a more individualized therapeutic roadmap.
buff.ly/Da8ENXI
📣 I am not at #AACR26 this year, but my colleague Holly is! You can connect with her via the link below to LinkedIn. Learn all about our Sage Journals Oncology portfolio and opportunities for collaboration.
#AACR2026 #cancerresearch
📣 I am not at #AACR26 this year, but my colleague Holly is! You can connect with her via the link below to LinkedIn. Learn all about our Sage Journals Oncology portfolio and opportunities for collaboration.
#AACR2026 #cancerresearch
#ADCs are reshaping breast oncology, alongside new questions on sequencing, biomarkers, and toxicity management. Explore this Ther Adv Med Oncol special collection, guest edited by Paolo Tarantino, MD, and Ilana Schlam, MD.
buff.ly/pZycpW5
#BreastCancer #ADCs #MedicalOncology #OncologyResearch
Dosimetric Performance Analysis of Pediatric Based Halcyon™ Volumetric Arc Therapy-Based Lung-Sparing Total Body Irradiation
@tcrtcancer.bsky.social
@journals.sagepub.com
@upenn.edu
journals.sagepub.com/doi/10.1177/...
#cancertreatment #radiationtherapy #oncology #lungcancer #openaccess
Patterns of care and associated social determinants of health in the definitive treatment of localized muscle-invasive bladder cancer patients
Bladder Cancer
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#radiationtreatment #oncology #openaccess
Individualized decitabine dosing for post-HSCT maintenance in MDS and secondary AML from MDS: long-term outcomes from the PODAC trial and matched controls
Therapeutic Advances in Hematology
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#stemcelltransplantation #cancer #oncology
Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023
@tagastroenterol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#gastroenterology #cancertreatment #oncology #openaccess
Expanding the Role of Oncology Nursing in Low- and Middle-Income Countries: An Urgent Imperative
@cancer-control.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#healthcare #cancer #openaccess
An Investigation into Planned Dose Preservation of Biology-guided Radiotherapy Under Various Radiopharmaceutical Uptake Conditions
@tcrtcancer.bsky.social
@journals.sagepub.com
@stanforduniversity.bsky.social
#RefleXionMedical
journals.sagepub.com/doi/10.1177/...
#PET #MedicalImaging #Oncology
Podcast article: Shifting treatment paradigm in multiple myeloma: a podcast integrating ASH 2025 data with patient and physician perspectives
Therapeutic Advances in Hematology
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#bispecific #CAR-T #cancertreatment #oncology #openaccess
Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligence
@tcrtcancer.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#deeplearning #medicalimaging #diagnosis #prognosis #oncology #openaccess
#EndometrialCancer is increasingly understood as a group of molecularly distinct diseases. This review in Ther Adv Med Oncol examines hereditary cancer syndromes predisposing to EC and their implications for prognosis, biology, and emerging therapeutic approaches.
buff.ly/9UGqCj9
#CancerGenetics
A new Special Collection in Ther Adv Med Oncol will explore emerging treatment strategies in HR+HER2‑ advanced #BreastCancer, a field marked by rapid therapeutic expansion and ongoing unmet need.
Submission deadline: 14 Dec 2026
buff.ly/Da8ENXI
#HRpositive #HER2negative #MedicalOncology
🆕New research online!
⚠️Case reports have raised concerns about the possibility of #psoriasis new-onset or exacerbation under B-cell depleting therapies for #MultipleSclerosis.
📊Here, Patricia Kirschner et al analyze multicentre data from 3000+ patients:
journals.sagepub.com/doi/full/10....
Does EV-D68 amplify TB immunopathology?
Case series suggests coinfection may worsen lung inflammation, with clinical response seen after corticosteroid escalation.
A reminder to consider viral triggers in atypical TB courses.
journals.sagepub.com/doi/10.1177/...
🧳Will you be at the @AANmember Annual Meeting in Chicago?
We highly recommend this session on Stiff Person Syndrome Spectrum (SPS)!
Our Deputy Editor, Professor Marinos Dalakas, will be
presenting on the clinical diagnosis of Stiff Person Syndrome:
www.aan.com/msa/Public/E...
Also by Marinos Dalakas is this new article in our Special Collection CAR T-cells in Autoimmune Neurological Disorders:
How can CAR T-cell therapies change the therapeutic algorithms in autoimmune neurology?
journals.sagepub.com/doi/full/10....
#Glioblastoma care depends on high‑quality, integrated clinical decision‑making across the full treatment pathway. Ther Adv Med Oncol invites submissions to a special collection on clinically actionable advances in glioblastoma care.
Submission deadline: 11 Dec 2026
buff.ly/8jRyYqj
#NeuroOncology
A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation
doi.org/10.1177/0963...
#GMP #cell
@journals.sagepub.com
Long-term outcomes of autologous cell transplantation for patients with non-TAO autoimmune disease–related critical limb ischemia
doi.org/10.1177/0963...
#ischemia #limb
@journals.sagepub.com
The landscape of mitochondrial transplantation: A bibliometric analysis
doi.org/10.1177/0963...
#mitochondrial #transplantation
@journals.sagepub.com
Gelatin sponge loaded with hypoxic human umbilical cord mesenchymal stem cell exosomes promotes healing of enterocutaneous fistula
doi.org/10.1177/0963...
#MSC #exosome
@journals.sagepub.com
A real‑world retrospective study in Ther Adv Med Oncol examined the prevalence of HER2‑ultralow disease in HR+/HER2‑negative metastatic breast cancer and reported comparable first‑line chemotherapy outcomes to HER2‑low disease.
buff.ly/Q7JaadR
#BreastCancer #HER2 #MedicalOncology #RealWorldEvidence
A new study in Technology in Cancer Research & Treatment explores PET-guided radiotherapy under varying uptake conditions, revealing key insights into its real-world reliability and limits.
journals.sagepub.com/doi/10.1177/...
@journals.sagepub.com
#Radiotherapy #PET #MedicalPhysics #Imaging